Hardware Podcasts

018 - "The Optimist Plans for Forever" - with Sarfaraz Niazi

Let's Combinate · 2 Feb 2022 · 1h 29m

What this episode covers

Professor Sarfaraz Niazi, founder of Pharmaceutical Scientist Inc. and Adello Biologics (acquired by Kashiv Biosciences), explains his mission to make biosimilars accessible by reducing regulatory and manufacturing costs, including his patented single-pass HVAC system. He details the technical differences between biosimilars and generics, arguing that current US regulations are overly stringent and unscientific. Niazi also discusses his prolific output of over 50 patents and 50+ books, attributing his productivity to a strict daily writing routine and a philosophy of focusing on passion rather than hobbies.

Most relevant to

early-stage companies

Topics

Mentioned

Companies
Pharmaceutical Scientist Inc., Adello Biologics, Kashiv Biosciences, Abbott Labs
Products
MayaBio
Also
FDA, WHO

Related episodes from other shows

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 38m

    #380: Navigating the Complex World of Combination Products with Subhi Saadeh

    Subhi Saadeh, host of the Combinate Podcast and expert in combination products, discusses the regulatory complexities of integrating drugs, devices, and biologics, including the differences between US FDA and EU regulatory pathways. He explains the definitions of single entity, co-packaged, and cross-labeled products, and addresses common misconceptions about the differences between drug and device quality systems. Saadeh also shares his journey of starting the podcast to maintain consistent learning and production, highlighting the importance of lifelong learning and leveraging coaching to balance technical and business aspects of the MedTech industry.

    Medical & health devicesCertification & compliance
    8 chapters

  • Global Medical Device Podcast · 21m

    Sara Naab On Going From Idea to Funding to One of the Bay Area's Most Innovative Life Sciences Co's

    Sara Naab, co-founder and director of quality and marketing at Sandstone Diagnostics, discusses the journey of building Trak, an over-the-counter male fertility monitoring system comprising a mini centrifuge and companion app. She highlights manufacturing, regulatory hurdles with the FDA, and investor relations as the primary challenges, contrasting them with the relative ease of their design control and quality systems. Naab explains how the company leverages agile software methodologies and a culture of humor to navigate the sensitive nature of sperm testing and achieve recognition as one of the Bay Area's most innovative life sciences companies.

    Starting a product companyMedical & health devices
    9 chapters

  • How I Built This · 1h 06m

    Moderna and Flagship Pioneering: Noubar Afeyan

    Noubar Afeyan, co-founder of Moderna and founder of Flagship Pioneering, explains how his venture studio model incubated Moderna by combining scientific research, entrepreneurial talent, and capital under one roof. He details the rapid development of the mRNA-1273 COVID-19 vaccine, from receiving the viral sequence to generating a computer model in two days, and the subsequent scaling of manufacturing to billions of doses. Afeyan also reflects on his early career, including founding Perceptive Biosystems and his pivotal meeting with David Packard, which shaped his approach to innovation and risk-taking.

    Starting a product companyValidation & product-market fit
    8 chapters

  • Global Medical Device Podcast · 29m

    Meet a Guru: Tom Rish

    Tom Rish, a senior medical device guru at Greenlight Guru, discusses his background in orthopedic implants at Zimmer and his current role helping startups navigate regulatory frameworks. He emphasizes that regulations like FDA 21 CFR 820 and ISO 13485 are simple efficiencies rather than complex burdens, advising companies to 'right-size' their Quality Management Systems (QMS) by focusing only on immediate needs. Rish shares practical advice for one-person teams and early-stage companies, such as writing procedures while performing tasks to ensure they are efficient and avoiding the 'procedure overload' that leads to non-compliance. He highlights the importance of integrating documentation, like risk matrices and user needs, into the daily workflow to prevent last-minute 'non-stop paperwork' crises before submissions or audits.

    Quality & yieldValidation & product-market fit
    9 chapters

  • Additive Snack · 1h 02m

    When Production Overtakes Prototyping: Materialise’s Next Phase of AM

    Bart van der Schuren, CTO of Materialise, explains how the company transitioned from a 1995 service bureau to a production powerhouse, recently surpassing prototyping with serial manufacturing. He details the three pillars of Materialise—manufacturing, software, and medical applications—and highlights rapid adoption in hearing aids, dental, and drones, contrasted with the slow, recertification-heavy aerospace sector. Van der Schuren argues that AI-driven automation and in-situ quality control are critical for reducing New Product Introduction (NPI) costs and scaling production in regulated industries.

    Scaling productionAI & machine learning
    10 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.